Thomas Pabst

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten et al. · New England Journal of Medicine · 2009 · 818 citations · Full text

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

Mojca Jongen‐Lavrencic, Tim Grob, Diana Hanekamp et al. · New England Journal of Medicine · 2018 · 756 citations · Full text

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 444 citations · Full text

Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

Hans Theodor Eich, Volker Diehl, Helen Görgen et al. · Journal of Clinical Oncology · 2010 · 431 citations · Full text

Cytarabine Dose for Acute Myeloid Leukemia

Bob Löwenberg, Thomas Pabst, Edo Vellenga et al. · New England Journal of Medicine · 2011 · 405 citations · Full text